.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Federal Trade Commission
QuintilesIMS
Dow
Covington
US Department of Justice
Deloitte
Accenture
Harvard Business School

Generated: November 25, 2017

DrugPatentWatch Database Preview

Drugs with Dosage: INJECTABLE;INTRAMUSCULAR, INTRAVENOUS

« Back to Dashboard
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Wockhardt
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065391-001Apr 12, 2007APRXNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Wockhardt
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065391-002Apr 12, 2007APRXNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Wockhardt
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065391-003Apr 12, 2007APRXNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Teva Pharms
CEFUROXIME SODIUM
cefuroxime sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS064192-001Apr 16, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Teva Pharms
CEFUROXIME SODIUM
cefuroxime sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS064192-002Apr 16, 1998DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Bedford
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065465-001Aug 18, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Bedford
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065465-002Aug 18, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Bedford
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065465-003Aug 18, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Bedford
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065465-004Aug 18, 2008DISCNNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
Hospira Inc
CEFTRIAXONE
ceftriaxone sodium
INJECTABLE;INTRAMUSCULAR, INTRAVENOUS065230-001Aug 2, 2005APRXNoNo► Subscribe► Subscribe► SubscribeINJECTABLE;INTRAMUSCULAR, INTRAVENOUS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Accenture
Cipla
Citi
Queensland Health
Dow
Julphar
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot